The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence
Journal of Neuro-Oncology · 2026
DOI: 10.1007/s11060-025-05367-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2026. Verfasst von Johnathon W Evers Smith und 18 weiteren Autor:innen. Beteiligte Einrichtung: Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Radiosurgery, Glioblastoma, Brain Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The role of stereotactic radiosurgery (SRS) in the management of recurrent glioblastoma (rGB) is controversial. Here, we investigate how tumor characteristics impact patient outcomes following SRS. METHODS: An IRB-approved retrospective review of SRS-treated rGB patients was performed. Clinical, histological, molecular, imaging, and radiosurgical data were collected. Overall survival (OS) and progression free survival (PFS) were analyzed using Cox models. RESULTS: Forty-nine rGB patients (83 lesions) were treated; median age was 61 years (range: 21–78), median post-SRS follow-up was 9.2 months (range: 2.8–77.3). Median tumor volume and diameter at SRS were 2.0 cm3 and 1.4 cm, respectively. Median prescription dose was 24 Gy. Post-SRS, median OS and PFS was 10.7 (95% CI 8.3–13.0) and 3.8 months (95% CI 2.8–5.6), respectively. Multivariate analysis demonstrated improved OS with tumor volume ≤ 2 cm3 (p = 0.006), > 8 months from diagnosis to recurrence (p = 0.0003), and no loss of heterozygosity in tumor-suppressor rich chromosome 19q13 (p = 0.001). Median OS for patients with and without ≥ 2 of these features was 15.1 (95% CI 11.5–39.5) and 7.56 months (95% CI 5.3–11.8), respectively. Improved PFS was associated with Ki-67 index > 50% (p = 0.003), p53 staining ≥ 30% (p = 0.03), and > 8 months between diagnosis and recurrence (p = 0.05). Median PFS for patients with and without ≥ 2 of these features was 6.7 (95% CI 4.6–9.4) and 2.8 months (95% CI 2.3–4.1), respectively. CONCLUSIONS: SRS may be especially promising for rGB patients with favorable prognostic features, as patients with ≥ 2 of the identified favorable OS/PFS prognostic features experienced a 2x and 2.4x increase in OS/PFS, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
- Department of Neurosurgery, Cleveland Clinic Neurological Institute, Cleveland, OH, USA.
- Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
- Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA.
Zitieren
APA
Evers Smith, J. W., Alzate, J. D., Power, L., Wei, W., Chao, S. T., Siddiq, M., Prayson, R., Barnett, G. H., Mohammadi, A. M., Grabowski, M. M., Suh, J. H., Murphy, E. S., Yu, J. S., Balagamwala, E., Neyman, G., Stevens, G. H. J., Peereboom, D., Dhawan, A., & Angelov, L. (2026). The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05367-5
Vancouver
Evers Smith JW, Alzate JD, Power L, Wei W, Chao ST, Siddiq M, et al. The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence. Journal of Neuro-Oncology. 2026. doi:10.1007/s11060-025-05367-5
BibTeX
@article{EversSmith2026,
author = {Evers Smith, Johnathon W and Alzate, Juan D and Power, Landon and Wei, Wei and Chao, Samuel T and Siddiq, Mustafa and Prayson, Richard and Barnett, Gene H and Mohammadi, Alireza M and Grabowski, Matthew M and Suh, John H and Murphy, Erin S and Yu, Jennifer S and Balagamwala, Ehsan and Neyman, Gennady and Stevens, Glen H J and Peereboom, David and Dhawan, Andrew and Angelov, Lilyana},
title = {The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence},
journal = {Journal of Neuro-Oncology},
year = {2026},
doi = {10.1007/s11060-025-05367-5}
}
EUVIMED